Location of Repository

The role of protein degradation in neuronal cell death

By Joanna Marie Norman


In neuronal systems, the degradation of intracellular proteins, controlled by the\ud ubiquitin-proteasome system and autophagy, is of paramount importance for normal\ud cellular homeostasis. The dysfunction of either of these pathways leads to the\ud accumulation of protein aggregates, as seen in neurodegenerative conditions,\ud culminating in neuronal cell death. In the current study I investigated the cleavage of\ud the proteasome subunits, S1, S6´ and S5a in cerebellar granule neurons induced to\ud undergo apoptosis through the withdrawal of potassium. The cleavage of S1 and S6´\ud and the loss of proteasomal activity corresponded with the activation of caspase-3;\ud however the role of the proteasome was shown to be limited in this model as cells had\ud passed the death commitment point. In addition, I developed a multiubiquitinated\ud fluorescent sensor for the analysis of the proteasomal function on a single cell level,\ud and characterised its use in SH-SY5Y cells. I have also constructed epitope-tagged\ud plasmids encoding the autophagy-related proteins and examined their potential\ud regulation by cell death proteases in an in vitro cleavage assay. Most of the autophagy-related proteins were cleaved in the in vitro model and the potential cleavage sites\ud were identified for mutagenesis. The cleavage of Beclin 1 was also observed in\ud apoptotic cerebellar granule neuron lysates. Finally, I investigated the mechanisms by\ud which the HDACi, TSA, exerts a neuroprotective effect in cerebellar granule neurons. I\ud have demonstrated that it increases the expression of a number of BCL2 family\ud proteins, in particular MCL1, which was hypothesised to contribute to the\ud neuroprotection observed. Taken together, I have demonstrated in this thesis that there\ud are multiple levels of control during cell death; defining their importance is essential for\ud the development of future drug targets

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/7334

Suggested articles



  1. (1998). 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis.
  2. (2007). A calpain-like protease inhibits autophagic cell death.
  3. (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.
  4. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
  5. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis.
  6. (2001). A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.
  7. (2002). A cryptic protease couples deubiquitination and degradation by the proteasome.
  8. (2001). A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation.
  9. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
  10. (2006). A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.
  11. (2000). A gated channel into the proteasome core particle.
  12. (2005). A genomic and functional inventory of deubiquitinating enzymes.
  13. (2005). A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes.
  14. (1993). A membraneassociated complex containing the
  15. (1989). A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.
  16. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.
  17. (2006). A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.
  18. (2002). A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice.
  19. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.
  20. (2008). A picky eater: exploring the mechanisms of selective autophagy in human pathologies.
  21. (2002). A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal.
  22. (1998). A protein conjugation system essential for autophagy.
  23. (1995). A proteolytic pathway that recognizes ubiquitin as a degradation signal.
  24. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
  25. (1997). A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro.
  26. (1977). A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes.
  27. (2003). A transgenic mouse model of the ubiquitin/proteasome system.
  28. (1995). A ubiquitin mutant with specific defects in DNA repair and multiubiquitination.
  29. (2000). A ubiquitin-based tagging system for controlled modulation of protein stability.
  30. (2000). A ubiquitin-like system mediates protein lipidation.
  31. (2003). A unified model for apical caspase activation.
  32. (2003). A unified nomenclature for yeast autophagy-related genes.
  33. (2003). Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREBbinding protein.
  34. (1999). Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation.
  35. (1998). Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia.
  36. (2003). Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein,
  37. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
  38. (2007). Active-site directed probes to report enzymatic action in the ubiquitin proteasome system.
  39. (2005). Activity deprivation-dependent induction of the proapoptotic BH3-only protein Bim is independent of JNK/c-Jun activation during apoptosis in cerebellar granule neurons.
  40. (2005). Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib.
  41. (2006). Adaptive roles of programmed cell death during nervous system development.
  42. (2003). Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
  43. (2000). Aggresomes, inclusion bodies and protein aggregation.
  44. (1998). Aggresomes: A cellular response to misfolded proteins.
  45. (1998). Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
  46. (2007). Ambra1 regulates autophagy and development of the nervous system.
  47. (1999). An archaebacterial ATPase, homologous to ATPases in the eukaryotic 26 S proteasome, activates protein breakdown by 20 S proteasomes.
  48. An induced proximity model for caspase-8 activation.
  49. (2006). and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
  50. (2006). Anticancer activities of histone deacetylase inhibitors.
  51. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.
  52. (1998). Apaf1 is required for mitochondrial pathways of apoptosis and brain development.
  53. (1999). Apg16p is required for the function of the Apg12p-Apg5p conjugate in the yeast autophagy pathway.
  54. Apg7p/Cvt2p is required for the cytoplasm-to-vacuole targeting, macroautophagy, and peroxisome degradation pathways.
  55. (1999). Apg7p/Cvt2p: A novel protein-activating enzyme essential for autophagy.
  56. (2008). Apoptosis and autophagy: regulatory connections between two supposedly different processes.
  57. (1997). Apoptosis by death factor.
  58. (1995). Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis.
  59. (1997). Apoptosis in cerebellar granule neurones: involvement of interleukin-1 beta converting enzyme-like proteases.
  60. (2000). Apoptosis in the nervous system.
  61. (2008). Apoptosis in the pathogenesis of systemic lupus erythematosus.
  62. (2007). Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.
  63. (1996). Apoptosis induction resulting from proteasome inhibition.
  64. (2001). Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2.
  65. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
  66. (2008). Apoptosis: controlled demolition at the cellular level.
  67. (2004). Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.
  68. (2007). Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila.
  69. (2005). Atg9 cycles between mitochondria and the pre-autophagosomal structure in yeasts.
  70. (2006). ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome.
  71. (2005). ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins.
  72. (1980). ATPdependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation.
  73. (1998). Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.
  74. (1996). Autocatalytic processing of the 20S proteasome.
  75. (1996). Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly.
  76. (2006). Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG.
  77. (2005). autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death.
  78. (2007). Autophagosome formation: core machinery and adaptations.
  79. (2006). Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response.
  80. (2007). Autophagy gene-dependent clearance of apoptotic cells during embryonic development.
  81. (2005). Autophagy in cell death: an innocent convict?
  82. (2002). Autophagy in the eukaryotic cell.
  83. (2008). Autophagy in the pathogenesis of disease.
  84. (1999). Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution.
  85. (2006). Autophagy: a forty-year search for a missing membrane source.
  86. (2008). Autophagy: basic principles and relevance to disease.
  87. (2003). Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitinproteasome system.
  88. (2005). Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration.
  89. (1998). Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells.
  90. (1991). Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells.
  91. (2007). Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity.
  92. (1997). Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death.
  93. (1998). Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations.
  94. (1998). Bcl-2 accelerates the maturation of early sensory neurons.
  95. (2006). Bcl-2 family and the central nervous system: from rheostat to real complex.
  96. (2008). BCL-2 family regulation by the 20S proteasome inhibitor bortezomib.
  97. (2006). BCL-2 in the crosshairs: tipping the balance of life and death.
  98. (1993). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.
  99. (1996). BCL2 regulates neural differentiation.
  100. (2003). Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.
  101. (2008). Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking.
  102. (2005). BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
  103. (2001). Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion.
  104. (2003). Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1.
  105. (2005). Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis.
  106. (1984). Brain fodrin: Substrate for calpain I, an endogenous calcium-activated protease.
  107. (2002). c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons.
  108. (1994). C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2.
  109. (2001). CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis.
  110. (1999). Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons.
  111. (1998). Calcium, protease action, and the regulation of the cell cycle.
  112. (2005). Calpain cleavage regulates the protein stability of p73.
  113. (2006). Calpain is required for macroautophagy in mammalian cells.
  114. (2006). Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis.
  115. (2001). Cascade of caspase activation in signalosome and eIF3.
  116. (2000). Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis.
  117. (2004). Caspase Activation Inhibits Proteasome Function during Apoptosis.
  118. (1999). Caspase-3 expression by cerebellar granule neurons is regulated by calcium and cyclic AMP.
  119. (1998). Caspase-3 Is Required for α-Fodrin Cleavage but Dispensable for Cleavage of Other Death Substrates in Apoptosis.
  120. (1997). Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis.
  121. (2004). Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice.
  122. (2006). Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex.
  123. (2007). Caspase-7 mediated cleavage of proteasome subunits during apoptosis.
  124. (1999). Caspase-8 is required for cell death induced by expanded polyglutamine repeats.
  125. (1999). Caspase-9 can be activated without proteolytic processing.
  126. (2004). Caspase-dependent inactivation of proteasome function during programmed cell death in Drosophila and man.
  127. (1999). Caspases: preparation and characterization.
  128. (1997). Caspases: the executioners of apoptosis.
  129. (2007). Cell biology: autophagy and cancer.
  130. (2000). Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain.
  131. (1999). Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis.
  132. (1991). Cell death during development of the nervous system.
  133. (2002). Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.
  134. (1998). Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a.
  135. (2001). Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation.
  136. (2007). Chromatin modification of Apaf-1 restricts the apoptotic pathway in mature neurons.
  137. (2005). Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides.
  138. (2006). Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.
  139. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.
  140. (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis.
  141. (1999). Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.
  142. (1993). Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.
  143. (2002). Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.
  144. (2008). Cocaine regulates MEF2 to control synaptic and behavioral plasticity.
  145. (1984). Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates.
  146. (2008). Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests.
  147. (1983). Components of ubiquitinprotein ligase system. Resolution, affinity purification, and role in protein breakdown.
  148. (2002). Confirmation by FRET in individual living cells of the absence of significant amyloid beta -mediated caspase 8 activation.
  149. (1999). Conformation of the Bax C-terminus regulates subcellular location and cell death.
  150. (2002). Constitutive repression of E2F1 transcriptional activity through HDAC proteins is essential for neuronal survival.
  151. (2007). Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2.
  152. (2002). Convergence of multiple autophagy and cytoplasm to vacuole targeting components to a perivacuolar membrane compartment prior to de novo vesicle formation.
  153. (1997). Conversion of Bcl-2 to a Bax-like death effector by caspases.
  154. (1982). Covalent affinity" purification of ubiquitin-activating enzyme.
  155. (1999). Covalent modification of all members of human cullin family proteins by NEDD8.
  156. (2000). CREB-binding protein sequestration by expanded polyglutamine.
  157. (2003). Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration.
  158. (1999). Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation.
  159. (1997). Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family.
  160. (1995). Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution.
  161. (2007). Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein.
  162. (1994). Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer.
  163. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution.
  164. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase9 complex initiates an apoptotic protease cascade.
  165. (1999). Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation.
  166. (2000). Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1.
  167. (1962). Cytoplasmic components in hepatic cell lysosomes.
  168. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.
  169. (2004). Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis.
  170. (2003). Degradation of chromosomal DNA during apoptosis.
  171. (1994). Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons.
  172. (1999). Deubiquitinating enzymes: their diversity and emerging roles.
  173. (2005). Deubiquitination by proteasome is coordinated with substrate translocation for proteolysis in vivo.
  174. (2004). Development by self-digestion: molecular mechanisms and biological functions of autophagy.
  175. (1990). Developmental cell death: morphological diversity and multiple mechanisms.
  176. (2005). Different HECT domain ubiquitin ligases employ distinct mechanisms of polyubiquitin chain synthesis.
  177. (2006). Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
  178. (2007). Differential effects of AMPA receptor activation on survival and neurite integrity during neuronal development.
  179. (2001). Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury.
  180. (2004). Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain.
  181. (1997). Dissecting the assembly pathway of the 20S proteasome.
  182. (2001). Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells.
  183. (2007). Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3.
  184. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
  185. (1999). Distinct caspase cascades are initiated in receptor-mediated and chemicalinduced apoptosis.
  186. (2000). Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells.
  187. (2000). Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis.
  188. (2007). Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry.
  189. (2008). Downregulation of Mcl1 potentiates HDACi-mediated apoptosis in leukemic cells.
  190. (2007). Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.
  191. (2000). Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions.
  192. (2007). Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation.
  193. (1989). Dynamics of alpha-tubulin deacetylation in intact neurons.
  194. (2005). E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer.
  195. (2005). E3 ubiquitin ligase RNF2 interacts with the S6' proteasomal ATPase subunit and increases the ATP hydrolysis activity of S6'.
  196. (2008). Eating the enemy within: autophagy in infectious diseases. Cell Death Differ.
  197. (2006). Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
  198. (1999). Endogenous bax translocation in SH-SY5Y human neuroblastoma cells and cerebellar granule neurons undergoing apoptosis.
  199. (2006). Endoplasmic reticulum stress and trophic factor withdrawal activate distinct signaling cascades that induce glycogen synthase kinase-3 beta and a caspase-9-dependent apoptosis in cerebellar granule neurons.
  200. (2005). Endothelial nitric-oxide synthase antisense (NOS3AS) gene encodes an autophagy-related protein (APG9-like2) highly expressed in trophoblast.
  201. (2007). ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation.
  202. (2007). Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration.
  203. (2001). Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity.
  204. (2000). Evolution and function of ubiquitin-like protein-conjugation systems.
  205. (2001). Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis.
  206. (2008). Expansion and evolution of cell death programmes.
  207. (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.
  208. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons.
  209. (2004). Expression of Mcl-1 in cerebellar granule neurons is regulated by IGF-I in a developmentally specific fashion.
  210. (1999). Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: a role for BCL2?
  211. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.
  212. (1997). FLICE induced apoptosis in a cellfree system. Cleavage of caspase zymogens.
  213. (1997). FLICE is activated by association with the CD95 deathinducing signaling complex (DISC).
  214. (1996). FLICE, a novel FADDhomologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.
  215. (2004). Fluorescent probes for proteolysis: tools for drug discovery.
  216. (2002). Formation of the approximately 350-kDa Apg12-Apg5.Apg16 multimeric complex, mediated by Apg16 oligomerization, is essential for autophagy in yeast.
  217. (1999). Formation process of autophagosome is traced with Apg8/Aut7p in yeast.
  218. (2007). Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1.
  219. (1985). Functional heterogeneity of ubiquitin carrier proteins.
  220. (2006). Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking.
  221. (2004). Gene expression profiling of mouse postnatal cerebellar development using cDNA microarrays.
  222. (2005). Genes regulated in neurons undergoing transcription-dependent apoptosis belong to signaling pathways rather than the apoptotic machinery.
  223. (1986). Genetic control of programmed cell death in the nematode C.
  224. (2001). Genetic regulation of cerebellar development.
  225. (2006). GFP reporter mouse models of UPS proteolytic function.
  226. (2004). Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis.
  227. (2005). Growth factor regulation of autophagy and cell survival in the absence of apoptosis.
  228. (2004). HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons.
  229. (2005). HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.
  230. (2002). HDAC6 is a microtubule-associated deacetylase.
  231. (2005). HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.
  232. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
  233. (2006). HDAC6-p97/VCP controlled polyubiquitin chain turnover.
  234. (1978). Heat-Stable Polypeptide Component of an Atp-Dependent Proteolytic System from Reticulocytes.
  235. (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
  236. (2001). Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
  237. (2006). Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.
  238. (2001). Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
  239. (2006). Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.
  240. (2007). Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBPdependent transcriptional activation.
  241. (2007). Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.
  242. (2004). Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.
  243. (2002). Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.
  244. (2004). HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates.
  245. (2002). Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the conjugation of hApg12p to hApg5p.
  246. (2003). Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy.
  247. (2004). Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes.
  248. (1998). IAPs block apoptotic
  249. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
  250. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.
  251. (1998). Identification of mouse ULK1, a novel protein kinase structurally related to C. elegans UNC-51.
  252. (1981). Identification of the active amino acid residue of the polypeptide of ATP-dependent protein breakdown.
  253. (2002). Identification of ubiquitin-like protein-binding subunits of the 26S proteasome.
  254. (2003). Imaging 26S proteasome activity and inhibition in living mice.
  255. (2005). Impairment of starvationinduced and constitutive autophagy in Atg7-deficient mice.
  256. (2003). Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival.
  257. (2000). Induction and modulation of cerebellar granule neuron death by E2F-1.
  258. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.
  259. (2007). Inflammatory caspases and inflammasomes: master switches of inflammation.
  260. (2005). Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
  261. (2006). Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
  262. (2005). Inhibition of macroautophagy triggers apoptosis.
  263. (2005). Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.
  264. (2003). Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8.
  265. (2002). Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons.
  266. (2003). Interaction of the proteasome S5a/Rpn10 multiubiquitin-binding protein and the 8 kDa calcium-binding protein of Schistosoma mansoni.
  267. (2007). Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.
  268. (2000). Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases
  269. (2005). Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death.
  270. (2002). Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice.
  271. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptorinduced cell death.
  272. (1993). Isolation and characterization of autophagydefective mutants of Saccharomyces cerevisiae.
  273. (1975). Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells.
  274. (1994). Isolation of autophagocytosis mutants of Saccharomyces cerevisiae.
  275. (1977). Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24.
  276. (2008). JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy.
  277. (1996). Lamin proteolysis facilitates nuclear events during apoptosis.
  278. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
  279. (1994). Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons.
  280. (2005). Lithium induces autophagy by inhibiting inositol monophosphatase.
  281. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice.
  282. (2005). Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy.
  283. (2007). Mass spectrometry reveals the missing links in the assembly pathway of the bacterial 20 S proteasome.
  284. (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice.
  285. (2008). Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage.
  286. (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
  287. (2004). Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.
  288. (2005). Mechanism of lysine 48-linked ubiquitinchain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34.
  289. (2002). Mechanisms of Caspase Activation and Inhibition during Apoptosis.
  290. (2007). Mechanisms of chaperone-mediated autophagy.
  291. (2001). Mechanisms underlying ubiquitination.
  292. (2007). Mechanisms, biology and inhibitors of deubiquitinating enzymes.
  293. (2004). Methods for monitoring autophagy.
  294. (2001). Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis.
  295. (2000). Mitochondria as the central control point of apoptosis.
  296. (2006). Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
  297. (2002). Mitogenactivated protein kinase kinase 7 is activated during low potassium-induced apoptosis in rat cerebellar granule neurons.
  298. (2005). Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.
  299. (2003). Modification of CCAAT/enhancer-binding proteinbeta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO3.
  300. (1998). Modulation of cell death by Bcl-XL through caspase interaction.
  301. (2005). Molecular and Proteomic Characterisation of the ~700 kDa Apoptosome.
  302. (1992). Molecular cloning of the interleukin-1 beta converting enzyme.
  303. (1991). Molecular cloning, sequence, and tissue distribution of the human ubiquitinactivating enzyme E1.
  304. (2006). Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase.
  305. (1996). Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases.
  306. (2005). Monitoring of ubiquitindependent proteolysis with green fluorescent protein substrates.
  307. (2003). Mouse Apg16L, a novel WDrepeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate.
  308. (1999). Mouse ULK2, a novel member of the UNC-51-like protein kinases: unique features of functional domains.
  309. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis.
  310. (2006). mTOR and cancer: insights into a complex relationship.
  311. (2002). Multiple associated proteins regulate proteasome structure and function.
  312. (2004). Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system.
  313. (2003). Mutational analysis of N-Bak reveals different structural requirements for antiapoptotic activity in neurons and proapoptotic activity in nonneuronal cells.
  314. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
  315. (2002). Myeloid cell factor-1 is a critical survival factor for multiple myeloma.
  316. (1999). Neurogenetics of the cerebellar system.
  317. (1999). Neuronal activity-dependent cell survival mediated by transcription factor MEF2.
  318. (1998). Neuronal cell death.
  319. (2005). Neurons exclusively express N-Bak, a BH3 domain-only Bak isoform that promotes neuronal apoptosis.
  320. (2005). Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.
  321. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain.
  322. (1996). Non-erythroid α-spectrin breakdown by calpain and interleukin 1 β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis.
  323. (2004). On the sequential determinants of calpain cleavage.
  324. (1995). Opposing effects of thapsigargin on the survival of developing cerebellar granule neurons in culture.
  325. (1999). Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.
  326. (2005). p53 in neuronal apoptosis.
  327. (2003). Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain.
  328. (1997). Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity.
  329. (1998). Phosphorylation of ATPase subunits of the 26S proteasome.
  330. (2003). Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.
  331. (1998). Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons.
  332. (1996). Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species.
  333. (1998). Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.
  334. (2001). Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.
  335. (2007). Potential therapeutic applications of autophagy.
  336. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.
  337. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl2, until displaced by BH3-only proteins.
  338. (1997). Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells.
  339. (2005). Programmed cell death via mitochondria: different modes of dying.
  340. (1993). Promotion of granule cell survival by high K+ or excitatory amino acid treatment and Ca2+/calmodulin-dependent protein kinase activity.
  341. (1980). Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis.
  342. (1999). Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown.
  343. (1998). Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes.
  344. (2004). Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
  345. (2005). Proteasome inhibition elicits a biphasic effect on neuronal apoptosis via differential regulation of pro-survival and pro-apoptotic transcription factors. Mol Cell Neurosci.
  346. (2002). Proteasome inhibitors prevent cytochrome c release during apoptosis but not in excitotoxic death of cerebellar granule neurons.
  347. (1999). Proteasome inhibitors: a novel class of potent and effective antitumor agents.
  348. (1998). Proteasome inhibitors: valuable new tools for cell biologists.
  349. (2000). Proteasome Involvement and Accumulation of Ubiquitinated Proteins in Cerebellar Granule Neurons Undergoing Apoptosis.
  350. (2002). Proteasome subunit Rpn1 binds ubiquitin-like protein domains.
  351. (2005). Proteasome-associated proteins: regulation of a proteolytic machine.
  352. (2005). Proteasome: an emerging target for cancer therapy.
  353. (2002). Proteasomemediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro.
  354. (2004). Proteasomes and their Kin: Proteases in the Machine Age. Nature Reviews:
  355. (1998). Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein.
  356. (2000). Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis.
  357. (1995). Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade.
  358. (1995). Proteolysis of fodrin (non-erythroid spectrin) during apoptosis.
  359. (2005). Proteolysis: from the lysosome to ubiquitin and the proteasome.
  360. (2008). Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.
  361. (2004). Rab7 is required for the normal progression of the autophagic pathway in mammalian cells.
  362. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4.
  363. (2000). Recognition of the polyubiquitin proteolytic signal.
  364. (2007). Recovery of learning and memory is associated with chromatin remodelling.
  365. (2001). Recruitment, activation and retention of caspases-9 and3 by Apaf-1 apoptosome and associated XIAP complexes.
  366. (1998). Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.
  367. (1998). Regulated targeting of BAX to mitochondria.
  368. (2007). regulates autophagy and tumorigenesis.
  369. (2004). Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8.
  370. (2003). Regulation of apoptosis: the ubiquitous way.
  371. (1997). Regulation of cell migration by the calcium-dependent protease calpain.
  372. (2008). Regulation of macroautophagy by mTOR and Beclin 1 complexes.
  373. (2000). Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4.
  374. (1979). Resolution of the ATP-dependent proteolytic system from reticulocytes: a component that interacts with ATP.
  375. (2003). Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.
  376. (2003). Rheb promotes cell growth as a component of the insulin/TOR signalling network.
  377. (2006). Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes.
  378. (2004). Role for Rab7 in maturation of late autophagic vacuoles.
  379. (2004). Role of Bcl-2 family proteins in a nonapoptotic programmed cell death dependent on autophagy genes.
  380. (1999). Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis.
  381. (2001). Role of oxidative stress in the apoptotic cell death of cultured cerebellar granule neurons.
  382. (2002). Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome.
  383. Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells.
  384. (2003). Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis.
  385. (2005). Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
  386. (1998). Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.
  387. (2007). siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy.
  388. (1997). Sitedirected mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility.
  389. (2006). Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes.
  390. (2002). Straindependent neurodevelopmental abnormalities in caspase-3-deficient mice.
  391. (2005). Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1.
  392. (2000). Structural basis for the activation of 20S proteasomes by 11S regulators.
  393. (2005). Structural basis for the specificity and catalysis of human Atg4B responsible for mammalian autophagy.
  394. (2008). Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes.
  395. (1994). Structure and mechanism of interleukin-1 beta converting enzyme.
  396. (1997). Structure of 20S proteasome from yeast at 2.4 A resolution.
  397. (2000). Structure of a c-CblUbcH7 complex: RING domain function in ubiquitin-protein ligases.
  398. (1992). Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2).
  399. (2007). Structure of Atg5.Atg16, a complex essential for autophagy.
  400. (2000). Structure of GATE-16, membrane transport modulator and mammalian ortholog of autophagocytosis factor Aut7p.
  401. (1994). Structure of tetraubiquitin shows how multiubiquitin chains can be formed.
  402. (2005). Structure-function relationship of Atg12, a ubiquitin-like modifier essential for autophagy.
  403. (1997). Substrate specificities of caspase family proteases.
  404. (1996). substrates for the apoptotic mediator CPP32.
  405. (2003). SUMO-2/3 regulates topoisomerase II in mitosis.
  406. (2006). SVM-based prediction of caspase substrate cleavage sites.
  407. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
  408. (2002). Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
  409. (2002). The Apaf-1 apoptosome: a large caspase-activating complex.
  410. (2003). The apoptosis/necrosis transition in cerebellar granule cells depends on the mutual relationship of the antioxidant and the proteolytic systems which regulate ROS production and cytochrome c release en route to death.
  411. (2008). The Atg1 Kinase Complex Is Involved in the Regulation of Protein Recruitment to Initiate Sequestering Vesicle Formation for Nonspecific Autophagy in Saccharomyces cerevisiae.
  412. (2007). The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy.
  413. (2008). The Atg18-Atg2 complex is recruited to autophagic membranes via phosphatidylinositol 3-phosphate and exerts an essential function.
  414. (2008). The BCL-2 protein family: opposing activities that mediate cell death.
  415. (2006). The benzamide MS-275 is a potent, long-lasting brain regionselective inhibitor of histone deacetylases.
  416. (2000). The biochemistry of apoptosis.
  417. (2001). The C-terminal region of an Apg7p/Cvt2p is required for homodimerization and is essential for its E1 activity and E1-E2 complex formation.
  418. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.
  419. (1998). The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9.
  420. (1992). The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death.
  421. (2001). The calpain family and human disease.
  422. (2003). The calpain system.
  423. (1999). The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study.
  424. (2008). The central unit within the 19S regulatory particle of the proteasome.
  425. (2003). The COOH terminus of GATE-16, an intra-Golgi transport modulator, is cleaved by the human cysteine protease HsApg4A.
  426. (2007). The crystal structure of Atg3, an autophagy-related ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation.
  427. (2000). The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium.
  428. (2004). The crystal structure of microtubule-associated protein light chain 3, a mammalian homologue of Saccharomyces cerevisiae Atg8.
  429. (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.
  430. (2005). The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes.
  431. (1972). The effect of potassium on neuronal differentiation in cultures of dissociated newborn rat cerebellum.
  432. (2005). The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function.
  433. (2000). The hallmarks of cancer.
  434. (2000). The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.
  435. (2000). The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7.
  436. (2003). The mouse APG10 homologue, an E2-like enzyme for Apg12p conjugation, facilitates MAP-LC3 modification.
  437. (2008). The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
  438. (2001). The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation.
  439. (1999). The proteasome, a novel protease regulated by multiple mechanisms.
  440. (2002). The proteasome: a novel target for cancer chemotherapy.
  441. (2004). The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 1695,
  442. (2004). The protein structures that shape caspase activity, specificity, activation and inhibition.
  443. (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.
  444. (2000). The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway.
  445. (2004). The role of autophagy during the early neonatal starvation period.
  446. (1987). The role of depolarization in the survival and differentiation of cerebellar granule cells in culture.
  447. (2003). The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.
  448. (2006). The stop signal revised: immature cerebellar granule neurons in the external germinal layer arrest pontine mossy fiber growth.
  449. (2001). The substrate translocation channel of the proteasome.
  450. (2006). The therapeutic potential of the calpain family: new aspects.
  451. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.
  452. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.
  453. (1999). The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
  454. (1999). The ubiquitin-proteasome pathway and pathogenesis of human diseases.
  455. (1994). The ubiquitin-proteasome proteolytic pathway.
  456. (2001). Themes and variations on ubiquitylation.
  457. (1984). Thermolability of ubiquitinactivating enzyme from the mammalian cell cycle mutant ts85.
  458. (2007). Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3.
  459. (1996). TNFdependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.
  460. (2000). Tor-mediated induction of autophagy via an Apg1 protein kinase complex.
  461. (1998). Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast.
  462. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
  463. (2003). TRAIL-induced signalling and apoptosis.
  464. (1998). Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution.
  465. (2004). transport from the preautophagosomal structure.
  466. (2007). Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
  467. (2001). Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae.
  468. (2003). U-box proteins as a new family of ubiquitin ligases.
  469. (1991). UBA 1: an essential yeast gene encoding ubiquitin-activating enzyme.
  470. (2007). UBE1L2, a novel E1 enzyme specific for ubiquitin.
  471. (2005). Ubiquitin and ubiquitin-like proteins as multifunctional signals.
  472. (1985). Ubiquitin carboxyl-terminal hydrolase acts on ubiquitin carboxyl-terminal amides.
  473. (1984). Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85.
  474. (1980). Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes.
  475. (2006). Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
  476. (1982). Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation.
  477. (1987). Ubiquitin-aldehyde: a general inhibitor of ubiquitinrecycling processes.
  478. (2004). Ubiquitin, proteasome and parkin.
  479. (2004). Ubiquitin: a Nobel protein.
  480. (2005). Ubiquitylation and cell signaling.
  481. (1998). Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle.
  482. (2005). Upregulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium.
  483. (2006). Upregulation of TRAILR2 is not involved in HDACi mediated sensitization to TRAIL-induced apoptosis.
  484. (2007). Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharideinduced dopaminergic neurotoxicity.
  485. (2004). Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.
  486. (2003). Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition.
  487. (1998). WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation.
  488. (1993). Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.
  489. (2007). Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.